Physician profile
Rita Patrick
NPI 1033644273
$800.60
in general payments reported to CMS, 2019-2025
10 companies · $175 in 2025
The $175 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $55.40 · 2021: $310 · 2022: $182 · 2023: $77.54 · 2025: $175.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $261.70 | 2020-2022 | |
| Janssen Pharmaceuticals, INC | $146.70 | 2020-2022 | |
| Genzyme Corporation | $120.82 | 2025 | |
| Novartis Pharmaceuticals Corporation | $74.27 | 2021-2023 | |
| Abiomed | $54.48 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $49.84 | 2021-2023 | Jardiance |
| Merck Sharp & Dohme LLC | $42.73 | 2022-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $27.00 | 2021 | |
| Cmp Pharma, INC. | $11.82 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.24 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rita Patrick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.